One-quarter of older U.S. adults may be overtreated for diabetes

(HealthDay)—One-quarter of older adults with type 2 diabetes in the United States are tightly controlled using glucose-lowering medications with a high risk of hypoglycemia, according to a study published in the June issue of the Journal of the American Geriatrics Society. Suzanne V. Arnold, M.D., from the University of Missouri-Kansas City, and colleagues examined the proportion of older adults with […]

Continue reading »

Novel PET imaging method could track and guide therapy for type 1 diabetes

Researchers have discovered a new nuclear medicine test that could improve care of patients with type 1 diabetes. The new positron emission tomography (PET) imaging method could measure beta-cell mass, which would greatly enhance the ability to monitor and guide diabetes therapies. This study is reported in the featured article of the month in The Journal of Nuclear Medicine‘s August […]

Continue reading »

A 3-pronged plan to cut type 2 diabetes risk

(HealthDay)—The type 2 diabetes tide remains unchecked in the United States, as does pre-diabetes—having a blood sugar level higher than normal, but not high enough for a diabetes diagnosis. A U.S. Centers for Disease Control and Prevention report found that about 30 million Americans—roughly 10 percent of the population—have type 2 diabetes. What’s more, over 80 million have pre-diabetes, which, […]

Continue reading »

Self-monitoring of type 2 diabetes reduces follow-up costs by more than half

Self-monitoring of type 2 diabetes used in combination with an electronic feedback system results in considerable savings on health care costs especially in sparsely populated areas, a new study from the University of Eastern Finland shows. Self-monitoring delivers considerable savings on the overall costs of type 2 diabetes care, as well as on patients’ travel costs. Glycated hemoglobin testing is […]

Continue reading »

Researchers identify method to diagnose cancer in patients with early onset diabetes

Patients diagnosed with pancreatic cancer can develop elevated blood sugar levels up to three years before their cancer diagnosis, according to the results of a study by Mayo Clinic researchers published the journal Gastroenterology. “Pancreatic cancer is rapidly fatal after its diagnosis, with average survival of six months,” says Suresh Chari, M.D., a gastroenterologist at Mayo Clinic. “It has also […]

Continue reading »

Common diabetes drug found safe for most diabetics with kidney disease

Results of a large-scale study suggest that the oral diabetes drug metformin is safe for most diabetics who also have chronic kidney disease (CKD). The study of more than 150,000 adults by Johns Hopkins Medicine investigators found that metformin’s association with the development of a life-threatening condition called lactic acidosis was seen only among patients with severely decreased kidney function. […]

Continue reading »
1 2 3 4 5 6